DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

Celgene (NASDAQ: CELG)

116.48 3.66 (3.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $116.48 3.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.20
Previous Close $112.82
Daily Range $114.56 - $116.50
52-Week Range $66.85 - $119.84
Market Cap $93.0B
P/E Ratio 59.07
Dividend (Yield) $0.00 (0.0%)
Volume 6,092,444
Average Daily Volume 4,324,660
Current FY EPS $3.26





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Top Healthcare Stocks to Buy for 2015

Our Foolish insight into five healthcare stocks that could head higher next year.

Jim Cramer's 'Mad Money' Recap: 10 Reasons We'll Have a Santa Claus Rally

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield

Assessing Gilead's Reality-Perception Gap

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Biotech Weekly: Top Ideas From The San Antonio Breast Cancer Symposium

3 Stocks To Buy in a Market Crash

Johnson & Johnson, Celgene Corp, and Edwards Lifesciences Corp. may be good investments if markets stumble.

VHT, CELG, MDT, LLY: ETF Inflow Alert

Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson

Novartis AG and Amgen Inc. have promising new psoriasis drugs that could challenge Johnson & Johnson's Stelara for market share.

#PreMarket Primer: Monday, December 15: Hostages Taken In Downtown Sydney

See More CELG News...

CELG's Top Competitors

CELG $116.48 (3.24%)
Current stock: CELG
AMGN $168.48 (3.06%)
Current stock: AMGN
GILD $105.54 (3.07%)
Current stock: GILD
$0.00 (0.00%)
Current stock: